ent-Abietane-type lactones with anti-inflammatory activity from Euphorbia helioscopia

Phytochemistry. 2025 Jan:229:114313. doi: 10.1016/j.phytochem.2024.114313. Epub 2024 Oct 24.

Abstract

Euphohelinodes D-I (1-6), six previously unreported ent-abietane lactones, along with two known analogues (7 and 8), were isolated from the anti-inflammatory fraction extracted from E. helioscopia by a bioactivity-guided isolation. Their structures were characterized using a combination of spectroscopic data interpretation, single-crystal X-ray diffraction and ECD analysis. The anti-inflammatory activity of these compounds was evaluated by measuring their inhibitory effects on NO production in LPS-stimulated RAW264.7 macrophages. The most active candidate, euphohelinode H (5), had better inhibitory activity against NO production with an IC50 value of 30.23 ± 2.33 μM. Further study revealed that 5 significantly suppressed the expressions of iNOS and COX-2 through the NF-κB signaling pathway.

Keywords: Anti-inflammatory activity; Euphohelinodes D–I; Euphorbia helioscopia L.; Euphorbiaceae; ent-Abietane lactones.

MeSH terms

  • Abietanes* / chemistry
  • Abietanes* / isolation & purification
  • Abietanes* / pharmacology
  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / isolation & purification
  • Anti-Inflammatory Agents* / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / isolation & purification
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Cyclooxygenase 2 / metabolism
  • Dose-Response Relationship, Drug
  • Euphorbia* / chemistry
  • Lactones* / chemistry
  • Lactones* / isolation & purification
  • Lactones* / pharmacology
  • Lipopolysaccharides* / antagonists & inhibitors
  • Lipopolysaccharides* / pharmacology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • Molecular Structure
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide* / antagonists & inhibitors
  • Nitric Oxide* / biosynthesis
  • RAW 264.7 Cells
  • Structure-Activity Relationship

Substances

  • Lactones
  • Abietanes
  • Nitric Oxide
  • Lipopolysaccharides
  • Anti-Inflammatory Agents
  • NF-kappa B
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Anti-Inflammatory Agents, Non-Steroidal